superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
- Valid from
- 2022-03-31
- Valid until
- 2022-06-30
- Published
- 2022-05-06
- Recorded by AsOf
- 2026-11-08
- Checked
- 2026-11-08 · parsed from the SEC filing
- Confidence
- 0.95
- Replaced by
- 8,521,000,000 United States dollar
Sources
Cite this claim
Plain text
AsOf. "AbbVie cash and equivalents: 6,098,000,000 United States dollar", as of 2022-03-31 (until 2022-06-30). Claim clm_C8B5152DE66D, https://asof.is/claim/clm_C8B5152DE66D, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1551152/000155115222000017/0001551152-22-000017-index.htm.
APA
AsOf. (2022). AbbVie cash and equivalents: 6,098,000,000 United States dollar (as of 2022-03-31 (until 2022-06-30)) [Record clm_C8B5152DE66D]. Retrieved November 9, 2026, from https://asof.is/claim/clm_C8B5152DE66D (source: https://www.sec.gov/Archives/edgar/data/1551152/000155115222000017/0001551152-22-000017-index.htm)
BibTeX
@misc{asof_clm_C8B5152DE66D,
author = {AsOf},
title = {AbbVie cash and equivalents: 6,098,000,000 United States dollar},
year = {2022},
howpublished = {\url{https://asof.is/claim/clm_C8B5152DE66D}},
note = {Claim clm\_C8B5152DE66D, as of 2022-03-31 (until 2022-06-30); source: https://www.sec.gov/Archives/edgar/data/1551152/000155115222000017/0001551152-22-000017-index.htm},
urldate = {2026-11-09}
}Supersedes
On the record
/claim/clm_C8B5152DE66D.md/v1/claims/clm_C8B5152DE66Dsubmit a correction